Planta Med 2020; 86(05): 364-372 DOI: 10.1055/a-1095-1129
Formulation and Delivery Systems of Natural Products
Original Papers
Georg Thieme Verlag KG Stuttgart · New York
Development of Lipid-Based Nanocarriers for Increasing Gastrointestinal Absorption of Lupinifolin
Jidapa Musika
School of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand
,
Nuannoi Chudapongse
School of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand
› Author AffiliationsSupported by:
Achievement Scholarship of Thailand (SAST)
SUT-D5710256
Supported by:
Suranaree University of Technology (SUT) and the Office of the Higher Education Commission under NRU Project of Thailand
CoE 2559
Lupinifolin, a plant flavonoid, has been reported to possess various pharmacological effects. It most likely exerts low oral bioavailability because of poor water solubility. The objective of this study was to develop lipid nanocarriers as drug delivery systems to increase the gastrointestinal absorption of lupinifolin extracted from Albizia myriophylla. Three types of nanocarriers, lupinifolin-loaded solid lipid nanoparticles, lupinifolin-loaded nanostructured lipid carriers, and lupinifolin-loaded nanoemulsions, were prepared by an emulsification-sonication technique. All three types of nanocarriers loaded with lupinifolin, lupinifolin-loaded solid lipid nanoparticles, lupinifolin-loaded nanostructured lipid carriers, and lupinifolin-loaded nanoemulsions, were successfully synthesized. The lipid components chosen to formulate nanocarriers were tripalmitin and/or medium chain triglyceride. Physicochemical characterizations along with releasing profiles of lupinifolin-loaded lipid nanocarriers were compared. It was found that the best lipid nanocarrier for lupinifolin was lupinifolin-loaded nanostructured lipid carriers, which demonstrated the particle size of 151.5 ± 0.1 nm, monodispersity distribution with a polydispersity index of 0.24, negative surface charge at − 41.2 ± 0.7 mV, high encapsulation (99.3%), and high loading capacity (5.0%). The obtained lupinifolin-loaded nanostructured lipid carriers exhibited prolonged release in a simulated circulatory system but produced a low release in gastrointestinal conditions (3.7%). Intestinal permeability of the nanocarriers was further evaluated in everted intestinal sacs. The results from the ex vivo study indicated that lupinifolin-loaded nanostructured lipid carriers significantly increased the absorption of lupinifolin compared to the native form. In conclusion, lupinifolin-loaded lipid nanocarriers were successfully formulated as delivery systems to enhance its oral bioavailability. Further in vivo experiments are needed to validate the results from this study.
The observed morphology of yellow needle-shaped lupinifolin crystals, 1H and 13C NMR spectra of this lupinifolin material, a pseudoternary phase diagram, correlation spectroscopy (COSY), and mass spectra for lupinifolin are available as Supporting Information.
4
Sutthivaiyakit S,
Thongnak O,
Lhinhatrakool T,
Yodchun O,
Srimark R,
Dowtaisong P,
Chuankamnerdkarn M.
Cytotoxic and antimycobacterial prenylated flavonoids from the roots of Eriosema chinense
. J Nat Prod 2009; 72: 1092-1096
6
Ahn J,
Kim YM,
Chae HS,
Choi YH,
Ahn HC,
Yoo H,
Kang M,
Kim J,
Chin YW.
Prenylated flavonoids from the roots and rhizomes of Sophora tonkinensis and their effects on the expression of inflammatory mediators and proprotein Convertase Subtilisin/Kexin Type 9. J Nat Prod 2019; 82: 309-317
8
Itoigawa M,
Ito C,
Ju-ichi M,
Nobukuni T,
Ichiishi E,
Tokuda H,
Nishino H,
Furukawa H.
Cancer chemopreventive activity of flavanones on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett 2002; 176: 25-29
9
Prasad SK,
Laloo D,
Kumar M,
Hemalatha S.
Antidiarrhoeal evaluation of root extract, its bioactive fraction, and lupinifolin isolated from Eriosema chinense
. Planta Med 2013; 79: 1620-1627
10
Sianglum W,
Muangngam K,
Joycharat N,
Voravuthikunchai SP.
Mechanism of action and biofilm inhibitory activity of lupinifolin against multidrug-resistant enterococcal clinical isolates. Microb Drug Resist 2019; 25: 1391-1400
11
Yusook K,
Weeranantanapan O,
Hua Y,
Kumkrai P,
Chudapongse N.
Lupinifolin from Derris reticulata possesses bactericidal activity on Staphylococcus aureus by disrupting bacterial cell membrane. J Nat Med 2017; 71: 357-366
13
Fasinu P,
Pillay V,
Ndesendo VMK,
du Toit LC,
Choonara YE.
Diverse approaches for the enhancement of oral drug bioavailability. Biopharm Drug Dispos 2011; 32: 185-209
14
Chirio D,
Gallarate M,
Peira E,
Battaglia L,
Muntoni E,
Riganti C,
Biasibetti E,
Capucchio MT,
Valazza A,
Panciani P,
Lanotte M,
Annovazzi L,
Caldera V,
Mellai M,
Filice G,
Corona S,
Schiffer D.
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment. Eur J Pharm Biopharm 2014; 88: 746-758
15
Choi KO,
Choe J,
Suh S,
Ko S.
Positively charged nanostructured lipid carriers and their effect on the dissolution of poorly soluble drugs. Molecules 2016; 21: E672
16
Hussein MZ,
Meihua JT,
Fakurazi S,
Ithnin H.
The evolutionary development in drug discovery and delivery. J Drug Deliv Sci Technol 2013; 23: 195-205
19
Schneider C,
Gordon ON,
Edwards RL,
Luis PB.
Degradation of curcumin: from mechanism to biological implications. J Agric Food Chem 2015; 63: 7606-7614
21
Chivapat S,
Chavalittumrong P,
Attawish A,
Soonthornchareonnon N.
Toxicity study of lupinifolin from stem of Derris reticulata craib. J Tradit Thai Altern Med 2009; 7: 146-155
25
Aditya NP,
So A,
Doktorovova S,
Souto EB,
Kim S,
Chang P,
Ko S.
Development and evaluation of lipid nanocarriers for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE). LWT – Food Sci Technol 2014; 59: 115-121
26
Yen C,
Chen Y,
Wu M,
Wang C,
Wu Y.
Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide. Int J Nanomedicine 2018; 13: 669-680
27
Patil H,
Feng X,
Ye X,
Majumdar S,
Repka MA.
Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. AAPS J 2015; 17: 194-205
28
Kobayashi I,
Ichikawa S,
Neves MA,
Kuroiwa T,
Nakajima M.
Formulation of lipid Micro/Nanodispersion Systems. In:
Ahmad MU.
Lipids in Nanotechnology. Urbana: AOCS Press; 2012: 95-134
30
Muzzarelli RAA.
Chitosan composites with inorganics, morphogenetic proteins and stem cells, for bone regeneration. Carbohydr Polym 2011; 83: 1433-1445
32
Hanaor D,
Michelazzi M,
Leonelli C,
Sorrell CC.
The effects of carboxylic acids on the aqueous dispersion and electrophoretic deposition of ZrO2
. J Eur Ceram Soc 2012; 32: 235-244
34
Tan BJ,
Liu Y,
Chang KL,
Lim BKW,
Chiu GNC.
Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int J Nanomedicine 2012; 7: 651-661
35
Mukhopadhyay P,
Prajapati AK.
Quercetin in anti-diabetic research and strategies for improved quercetin bioavailability using polymer-based carriers – a review. RSC Adv 2015; 5: 97547-97562
37
Das S,
Chaudhury A.
Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. J Am Assoc Pharm Sci 2011; 12: 13-15